BillionToOne, Inc. (BLLN)

↓ Download CSV

CIK 0002070849 · Nasdaq · Services-Medical Laboratories

  • Sector Services
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, BillionToOne, Inc. reported revenue of $305.11M, up 100.0% from the prior year. The company was profitable, with a net margin of 2.4% and a gross margin of 68.3%. It held $632.65M in total assets against $152.55M in total liabilities.

Key ratios (FY2025)

68.3%
Gross margin
5.3%
Operating margin
2.4%
Net margin
1.6%
Return on equity
+100.0%
Revenue growth (YoY)
Metric (FY)2025202420232022
Revenue$305.11M$152.58M$71.73M
Cost of Revenue$96.65M$71.67M$54.42M
Gross Profit$208.46M$80.92M$17.31M
Operating Income$16.02M-$47.15M-$69.50M
Net Income$7.45M-$41.57M-$82.68M
EPS (Diluted)$0.14$-4.12$-8.45
Total Assets$632.65M$302.06M
Total Liabilities$152.55M$134.31M
Shareholders' Equity$480.11M-$251.66M-$219.05M-$141.81M
Cash & Equivalents$495.98M$191.48M
Operating Cash Flow$24.59M-$41.38M-$53.67M
Capital Expenditures$8.88M$5.40M$6.17M
Shares Outstanding21.23M10.08M9.78M